Technepine: A high-affinity 99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging

Synapse

Volumn 22, Issue 3, 1996, Pages 239-246

  Madras, Bertha K ^a   Jones, Alun G ^b   Mahmood, Ashfaq ^b   Zimmerman, Robert E ^b   Garada, Basem ^b   Holman, B Leonard ^b   Davison, Alan ^c   Blundell, Paul ^d   Meltzer, Peter C ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d ORGANIX INC   (United States)

Author keywords

Cocaine; Dopamine; Parkinson's disease; SPECT imaging; WIN 35,428 or CFT

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CITALOPRAM; TECHNETIUM 99M; TROPARIL;

ARTICLE; BINDING AFFINITY; DOPAMINERGIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN CHEMISTRY; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; MACACA FASCICULARIS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGANOTECHNETIUM COMPOUNDS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPORTERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030068840     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199603)22:3<239::AID-SYN6>3.0.CO;2-D     Document Type: Article

References (45)

1. Ballinger, J.R., Gulenchyne, K.Y., and Hassan, M.N. (1989) Tc-99m spiperone dithiocarbamate. A potential radiopharmaceutical for dopamine receptor imaging with SPECT. Appl. Rad Isot., 40:547-549.
2. 125I]RTI-55: A potent ligand for dopamine transporters. Eur. J. Pharmacol., 194:133-134.
3. Brownell, A-L, Elmaleh, D.E., Meltzer, P.C., Shoup, T.M., Brownell, G.L., Fischman, A.J., and Madras, B.K. (in press) Cocaine congeners as PET imaging probes for dopamine terminals in normal and MPTP induced Parkinsonism in nonhuman primate brain. J. Nucl. Med.
4. 3H]CFT, in monkey brain. Soc. Neurosci. Abs., 15:252.
5. 3H]CFT in monkey brain. Synapse, 5:189-195.
6. CarrolL F.I., Abraham, P., Lewin, A.H., Parham, K.A., Boja, J.W., and Kuhar, M. (1992) Isopropyl and phenyl esters of 3 beta-(4-substituted phenyl)tropan-2 beta-carboxyiic acids. Potent and selective compounds for the dopamine transporter. J. Med. Chem., 35:2497-2500.
7. Clarke, R.L., Daum, S.J., Gambino, A.J., Aceto, M.D., Pearl, J., Levitt, M., Cumiskey, W.R., and Bogado, E.F. (1973) Compounds affecting the central nervous system. 4. 3β-Phenyltropane-2-carboxylic esters and analogs. J. Med. Chem., 16:1260-1267.
8. 99m/99Tc-DADT-benzovesamicol: A potential marker for cholinergic neurons. Nucl. Med. Biol., 21:197-203.
9. Fischman, A.J., Babich, J.W., Elmaleh, D.R., Barrow, S.A., Meltzer, P., Hanson, R.N., and Madras, B.K. (submitted) SPECT imaging of dopamine transporter sites in normal and MPTP treated rhesus monkeys.
10. Francesconi, L.C., Graczyk, G., Wehrli, S., Shaikh, S.N., McClinton, D.. Liu, S., Zibieta, J., and Kung, H.F. (1993) Synthesis and characterization of neutral MVO (M = Tc, Re) amine-thiol complexes containing a pendant phenylpiperidine group. Inorg. Chem., 32: 3114-3124.
11. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol., 34:423-431.
12. 3H]Nisoxetine binding in rat brain J. Neurochem., 64:2792-2800.
13. 11C-CFT and PET in a primate model of Parkinsonism. Neuro Reports, 3:265-268.
14. Heikkila, R.E., Cabbat, F.S., Manzino, L., and Duvoisin, R.C. (1979) Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: Dependence upon dopamine uptake inhibition. J. Pharmacol. Exp. Ther., 211: 189-194.
15. m-HMPAO and ASPECT. J. Nucl. Med., 31:1206-1210.
16. 123I]CIT. Eur. J. Pharmacol., 200:369-370.
17. Kaufman, M. J., and Madras, B.K. (1991) Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse, 9:43-49.
18. 125I]RTI-55. Synapse, 12:99-111.
19. 3H]WIN 35.428) accumulation in dopamine regions of monkey brain: Comparison of a mature and an aged monkey. Brain Res., 611:322-328.
20. 3H]CFT. Synapse, 9:177-187.
21. Kuhar, M.J., Sanchez-Roa, P.M., Wong, D.F., Dannals, R.F., Grigoridis, D.E., Lew, R., and Milberger, M. (1990) Dopamine transporter: Biochemistry, Pharmacology and Imaging. Eur. Neurol., 30:15-20.
22. Lever, S.Z., Baidoo, K.E., Mahmood, A., Matsumura, K., Scheffel, U., and Wagner, H.N. (1994) Novel technetium ligands with affinity for the muscarinic cholinergic receptor. Nucl. Med. Biol., 21:157-164.
23. 11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's disease. Ann. Neurol. Abs., 35:376-377.
24. 3H]Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther., 251:131-141.
25. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Pharmacol., 36: 518-524.
26. 3H]Lu19-005: Markers for cocaine receptors/dopamine nerve terminals in Parkinson's disease. Soc. Neurosci. Abs., 16:14.
27. 3H]cocaine receptors. Pharmacol. Biochem. Behav., 35:949-953.
28. Madras, B.K., Fahey, M.A., Kaufman, M.J., Spealman, R D., Schumacher, J., Isacson, O., Brownell, A.-L., Brownell, G L., and Elmaleh, D.R. (1991) Cocaine receptor probes in nonhuman and human brain: In vitro characterization and in vivo imaging. Soc. Neurosci. Abs., 17:190.
29. Madras, B.K. (1992) Brain imaging of the dopamine transporter. NIDA Brain Imaging Conference, Keystone, Co.
30. Madras, B.K., Elmaleh, D.R., Meltzer, P.C., Liang, A.Y., Brownell, G L., and Brownell, A.-L. (1994) Positron Emission Tomography of cocaine recognition sites on the dopamine transporter. NIDA Res. Monogr., 138:57-69.
31. Madras, B.K., Gracz, L.M., Kaufman, M.J., Meltzer, P.C., Elmaleh, D.E., and Fischman, A.J. (1995) A novel SPECT imaging agent detects total loss of the dopamine transporter in Parkinsonian monkeys. Soc. Neurosci. Abs., 21:1983.
32. 120I]β-CIT. J. Nucl. Med. Abs., 36:31P.
33. Meitzer, P.C., Liang, A.Y., Brownell, A.-L., Elmaleh, D.R., and Madras, B.K. (1993) Substituted 3-phenyltropane analogs of cocaine: Synthesis, inhibition of binding at cocaine recognition sites and positron emission tomography (PET) imaging. J. Med. Chem., 36:855-862.
34. Meltzer, P.C., Liang, A.Y., and Madras, B.K. (1994) The discovery of an unusually selective and novel cocaine analog: Difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem. 37:2001-2010
35. Meltzer, P.C., Liang, A.Y., and Madras, B.K. (in press) 2-Carbomethoxy-3-(diarylmethoxy)-1 αH,5αH-tropane analogs: Synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series. J. Med. Chem.
36. 11C-CFT: A pilot study. Synapse.
37. 2-metal conjugate. Bioconjugate Chem., 5:182-193.
38. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmiedebergs Arch. Pharmacol., 329:227.
39. Seeman, P. (1993) Receptor tables. Vol. 2: Drug Dissociation Constants for Neuroreceptors and Transporters. SZ Research, Toronto. Canada.
40. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann. Neurol., 38:589-598.
41. Singer, H.S., Hahn, I.-H., and Moran, T.H. (1991) Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann. Neurol., 30:558-562.
42. Tiihonen, J., Kuikka, J., Bergström, K., Hakola, P., Karhu, J., Olli-Pekka, R, and Föhr, J. (1995) Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med., 1:654-657.
43. van Dyke, C.H., Seibyl, J.P., Malison, R.T., Laruelle, M., Wallace, E., Zoghbi, S.S., Zea-Ponce, Y., Baldwin, R.M., Charney, D.S., Hoffer, P.B., and Innis, R.B. (1995) Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J. Nucl. Med., 36:1175-1181.
44. 11C]WIN 35,428. Synapse, 15:130-142.
45. Wong, D.F., Harris, J., Singer, H., Naudi, S., Yokoi, F., Marenco, S., Evans, A., Rousset, O., Ma, Y., Yaster, M., Hong, C., Ravert, H., Dannals, R.F., Breese, G., Kuhar, M.J., and Gjedde, A. (1995) Dopamine receptor transporter imaging in neuropsychiatric developmental disorders. J. Cereb. Blood Flow Metab., 15:S97.